Your session is about to expire
← Back to Search
PSMA PET Scan-Directed Therapy for Prostate Cancer
Study Summary
This trial studies how well a PET scan using fluciclovine helps to detect prostate cancer and if site-directed treatment to abnormalities found on the scan works well for treating patients with prostate cancer.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- I have ongoing hepatitis B or C.I am fully active or restricted in physically strenuous activity but can do light work.My PSA levels have been doubling in more than 3 months but less than 18 months.I am mentally capable of understanding and giving informed consent.My kidney function, measured by creatinine clearance, is adequate.My bilirubin levels are within the normal range, or I have Gilbert's syndrome with levels up to 3 times the normal.My PSA levels are between 0.2 and 10 ng/mL, confirmed by two tests.I cannot stay still for pictures of my insides.My prostate cancer has been confirmed by lab tests.My prostate cancer has not spread to other parts as shown by scans.I have had radiation therapy to the prostate area after surgery.I am 18 years old or older.I understand the study details and can consent.I have had cancer other than prostate cancer that needed treatment in the last 2 years, except for certain skin and bladder cancers.I have had surgery to remove my prostate.Your doctor believes you have less than 3 months to live.
- Group 1: Group I (fluciclovine PET/CT)
- Group 2: Group II (surgery, radiotherapy, abiraterone, prednisone)
- Group 3: Group III (abiraterone, prednisone)
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
In what medical situations is Radiation Therapy typically recommended?
"Radiation Therapy is frequently used to address scalp structure, and can also be utilized for treating conditions such as thyroiditis, ulcerative colitis, and varicella-zoster virus acute retinal necrosis."
Has Radiation Therapy been given the greenlight by the FDA?
"Our team at Power deemed radiation therapy to be a safe option, with a score of 2. This decision was based on the fact that this is currently in Phase 2 trials, meaning there's existing evidence for safety but not yet any data in regards to its efficacy."
Are there still openings to join this research project?
"Correct. Per the clinicaltrials.gov database, this medical trial is still open for enrollment and was first posted on September 30th 2020. In total, 165 individuals are being recruited from one centre location across the country."
Does the literature indicate any prior experimentation with Radiation Therapy?
"At present, there are 435 active clinical trials focusing on Radiation Therapy with 121 of them in their third phase. Locations running these studies span the entirety of the United States and include 18381 medical centres overall; however, a substantial amount remain within Duarte, California."
To what extent has this investigation been populated with participants?
"Affirmative. According to clinicaltrials.gov, this medical research was first announced on September 30th 2020 and is actively looking for participants. Specifically, 165 patients are being recruited at a single location."
Share this study with friends
Copy Link
Messenger